Works matching IS 08876924 AND DT 2011 AND VI 25 AND IP 12

Results: 20

Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients.

Published in:

Leukemia (08876924), 2011, v. 25, n. 12, p. 1834, doi. 10.1038/leu.2011.161

By:

Pardanani, A;
Guglielmelli, P;
Lasho, T L;
Pancrazzi, A;
Finke, C M;
Vannucchi, A M;
Tefferi, A

Publication type:

Article

Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia.

Published in:

2011

By:

Renneville, A;
Boissel, N;
Helevaut, N;
Nibourel, O;
Terré, C;
Pautas, C;
Gardin, C;
Thomas, X;
Turlure, P;
Reman, O;
Berthon, C;
Dombret, H;
Castaigne, S;
Preudhomme, C

Publication type:

Letter

Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.

Published in:

2011

By:

Dejean, E;
Renalier, M H;
Foisseau, M;
Agirre, X;
Joseph, N;
de Paiva, G R;
Al Saati, T;
Soulier, J;
Desjobert, C;
Lamant, L;
Prósper, F;
Felsher, D W;
Cavaillé, J;
Prats, H;
Delsol, G;
Giuriato, S;
Meggetto, F;
Prósper, F;
Cavaillé, J

Publication type:

journal article

The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories.

Published in:

2011

By:

Kohlmann, A;
Klein, H-U;
Weissmann, S;
Bresolin, S;
Chaplin, T;
Cuppens, H;
Haschke-Becher, E;
Garicochea, B;
Grossmann, V;
Hanczaruk, B;
Hebestreit, K;
Gabriel, C;
Iacobucci, I;
Jansen, J H;
te Kronnie, G;
van de Locht, L;
Martinelli, G;
McGowan, K;
Schweiger, M R;
Timmermann, B

Publication type:

journal article

Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study.

Published in:

Leukemia (08876924), 2011, v. 25, n. 12, p. 1877, doi. 10.1038/leu.2011.165

By:

Nowakowski, G S;
LaPlant, B;
Habermann, T M;
Rivera, C E;
Macon, W R;
Inwards, D J;
Micallef, I N;
Johnston, P B;
Porrata, L F;
Ansell, S M;
Klebig, R R;
Reeder, C B;
Witzig, T E

Publication type:

Article

GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells.

Published in:

2011

By:

Si, J;
Mueller, L;
Collins, S J

Publication type:

Letter

Impact of TP53 mutation and 17p deletion in mantle cell lymphoma.

Published in:

2011

By:

Halldórsdóttir, A M;
Lundin, A;
Murray, F;
Mansouri, L;
Knuutila, S;
Sundström, C;
Laurell, A;
Ehrencrona, H;
Sander, B;
Rosenquist, R

Publication type:

Letter

Gene expression profiling in the leukemic stem cell-enriched CD34<sup>+</sup> fraction identifies target genes that predict prognosis in normal karyotype AML.

Published in:

Leukemia (08876924), 2011, v. 25, n. 12, p. 1825, doi. 10.1038/leu.2011.172

By:

de Jonge, H J M;
Woolthuis, C M;
Vos, A Z;
Mulder, A;
van den Berg, E;
Kluin, P M;
van der Weide, K;
de Bont, E S J M;
Huls, G;
Vellenga, E;
Schuringa, J J

Publication type:

Article

Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia.

Published in:

2011

By:

Zhang, X;
Reis, M;
Khoriaty, R;
Li, Y;
Ouillette, P;
Samayoa, J;
Carter, H;
Karchin, R;
Li, M;
Diaz, L A;
Velculescu, V E;
Papadopoulos, N;
Kinzler, K W;
Vogelstein, B;
Malek, S N;
Diaz, L A Jr

Publication type:

Letter

Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model.

Published in:

Leukemia (08876924), 2011, v. 25, n. 12, p. 1815, doi. 10.1038/leu.2011.158

By:

Canale, S;
Cocco, C;
Frasson, C;
Seganfreddo, E;
Di Carlo, E;
Ognio, E;
Sorrentino, C;
Ribatti, D;
Zorzoli, A;
Basso, G;
Dufour, C;
Airoldi, I

Publication type:

Article

The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.

Published in:

2011

By:

Lenze, D;
Leoncini, L;
Hummel, M;
Volinia, S;
Liu, C G;
Amato, T;
De Falco, G;
Githanga, J;
Horn, H;
Nyagol, J;
Ott, G;
Palatini, J;
Pfreundschuh, M;
Rogena, E;
Rosenwald, A;
Siebert, R;
Croce, C M;
Stein, H

Publication type:

journal article

Eμ/miR-125b transgenic mice develop lethal B-cell malignancies.

Published in:

2011

By:

Enomoto, Y;
Kitaura, J;
Hatakeyama, K;
Watanuki, J;
Akasaka, T;
Kato, N;
Shimanuki, M;
Nishimura, K;
Takahashi, M;
Taniwaki, M;
Haferlach, C;
Siebert, R;
Dyer, M J S;
Asou, N;
Aburatani, H;
Nakakuma, H;
Kitamura, T;
Sonoki, T

Publication type:

journal article

Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice.

Published in:

2011

By:

Zhang, J;
Xiao, Y;
Guo, Y;
Breslin, P;
Zhang, S;
Wei, W;
Zhang, Z

Publication type:

journal article

In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels.

Published in:

2011

By:

Belloni, E;
Shing, D;
Tapinassi, C;
Viale, A;
Mancuso, P;
Malazzi, O;
Gerbino, E;
Dall'Olio, V;
Egurbide, I;
Odero, M D;
Bertolini, F;
Pelicci, P G

Publication type:

Correction Notice

A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia.

Published in:

2011

By:

Lancet, J E;
Ravandi, F;
Ricklis, R M;
Cripe, L D;
Kantarjian, H M;
Giles, F J;
List, A F;
Chen, T;
Allen, R S;
Fox, J A;
Michelson, G C;
Karp, J E

Publication type:

journal article

Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.

Published in:

Leukemia (08876924), 2011, v. 25, n. 12, p. 1797, doi. 10.1038/leu.2011.169

By:

Deckert, M;
Engert, A;
Brück, W;
Ferreri, A J M;
Finke, J;
Illerhaus, G;
Klapper, W;
Korfel, A;
Küppers, R;
Maarouf, M;
Montesinos-Rongen, M;
Paulus, W;
Schlegel, U;
Lassmann, H;
Wiestler, O D;
Siebert, R;
DeAngelis, L M

Publication type:

Article

Exposure to tungsten induces DNA damage and apoptosis in developing B lymphocytes.

Published in:

2011

By:

Guilbert, C;
Kelly, A D R;
Petruccelli, L A;
Lemaire, M;
Mann, K K

Publication type:

Letter

Anaplastic large cell lymphoma: the current state of play from a European prospective as presented at the second annual meeting of the European Research Initiative on ALCL, 27-28 June 2011.

Published in:

2011

By:

Merkel, O;
Kenner, L;
Turner, S D

Publication type:

Editorial

The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells.

Published in:

Leukemia (08876924), 2011, v. 25, n. 12, p. 1891, doi. 10.1038/leu.2011.175

By:

Monaghan, K A;
Khong, T;
Burns, C J;
Spencer, A

Publication type:

Article

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine.

Published in:

2011

By:

Voso, M T;
Fabiani, E;
Piciocchi, A;
Matteucci, C;
Brandimarte, L;
Finelli, C;
Pogliani, E;
Angelucci, E;
Fioritoni, G;
Musto, P;
Greco, M;
Criscuolo, M;
Fianchi, L;
Vignetti, M;
Santini, V;
Hohaus, S;
Mecucci, C;
Leone, G

Publication type:

Letter